This is consistent with clinical studies demonstrating that the allelic ratio of the JAK2 V617F mutation does not account for the clonal hematopoiesis in many ET patients [42], and that ET patients with the JAK2 V617F mutation tend to have PV-like features [43]. The gene discussed is JAK2; the disease is essential thrombocythemia.